TRENDING WELLNESS TOPIC: Newer Uses of GLP-1 Agonists

What is the problem? 
GLP-1 agonists have been approved by the FDA for management of obesity and diabetes, but recent clinical studies have shown potent efficacy for other important metabolic indications as well.  These medications have proven to be very effective but they do have side effects. Healthcare professionals need to know the pros and cons of using GLP-1 agonists, as well as assess the right candidates who may benefit from using them. 

How do we know this is a problem?
https://my.clevelandclinic.org/health/treatments/13901-glp-1-agonists
https://pubmed.ncbi.nlm.nih.gov/36566341
https://www.nejm.org/doi/full/10.1056/NEJMoa1607141
https://www.nejm.org/doi/full/10.1056/NEJMoa2307563

Proposed Learning Objectives:
At the conclusion of this activity, the learners will be able to:

• Identify different GLP-1 agonists available for use, including similarities and differences
• Assess potential candidates who may benefit from use of GLP-1 medications
• Evaluate potential contraindications to use along with monitoring for adverse events while on these medications

If your medical staff needs an update on newer uses for GLP-1 agonists, consider contacting our office to book a speaker at 877-505-4777 or info@speakersnetwork.com.

REFERENCES